The aim of the Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies, a select group of late-stage private companies, and investors to foster the development of important new medicines that will expand the industry’s pipeline. Public company presentations are 25 minutes in length, while Private Company presentations are 13 minutes in length, and will be reserved specifically for established private companies (past Series B round and >$25M raised to date).
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics or platform technologies. Service providers will not be considered. Please note, there are registration and presentation fees associated with presenting. Visit our Registration Page for more information.
All final qualifications are determined by BIO.
Companies that meet the stated criteria should apply using the link below. Please note that you will first need to create an account. Afterwards, you will be directed to the application page.